January 25, 2021
FinSMEs
Eli Lilly and Company Completes Purchase of Prevail Therapeutics
Eli Lilly and Company (NYSE:LLY) completed its...... See more »
January 25, 2021
FinSMEs
January 25, 2021
PR Newswire
January 25, 2021
FinSMEs
January 25, 2021
PR Newswire
Chairman & CEO
Christopher J. Schaber
Soligenix is a late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases. Read more